INS and Hyperinsulinemia: Sodium-glucose cotransport 2 (SGLT-2) inhibitors are a class of human anti-diabetic drugs that offer a novel therapeutic option for treating insulin dysregulation and hyperinsulinemia in horses through targeting renal glucose reabsorption.